Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
WXXWY WUXI BIOLGCS ADR
18.2200.0000.00%
Trading Session
01/27 09:30 ET
High
0.000
Open
0.000
Turnover
0.00
Low
0.000
Pre Close
18.220
Volume
0.00
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
No Data
News
Comment
Sign in to post a comment
HSI Sags 68 Pts; Yet BABA Rises
At open, $Hang Seng Index(800000.HK$ shed 68 pts or 0.3% to 21,678; $Hang Seng China Enterprises Index(800100.HK$ dipped 16 pts or 0.2% to 7,333; $Hang Seng TECH Index(800700.HK$ sank 13 pts or 0.3% to 4,493.
As to techs, $BABA-SW(09988.HK$ ose 0.5% to $114, as the market rumored that activist investor Ryan Cohen acquired BABA stakes and urged the company to conduct more buybacks. $TENCENT(00700.HK$ gained 0.1% to $370.6. $Meituan-W(03690.HK$ lifted 0.1% to $165.8.
$WUXI BIO(02269.HK$ slipped 2...
As to techs, $BABA-SW(09988.HK$ ose 0.5% to $114, as the market rumored that activist investor Ryan Cohen acquired BABA stakes and urged the company to conduct more buybacks. $TENCENT(00700.HK$ gained 0.1% to $370.6. $Meituan-W(03690.HK$ lifted 0.1% to $165.8.
$WUXI BIO(02269.HK$ slipped 2...
Like
Comment
Share
HKD1.3B Southbound Trading Net Outflow from TENCENT
There was HKD1.3 billion, HKD181.6 million and HKD43.7 million Southbound Trading net outflow from $TENCENT(00700.HK$ , $WUXI BIO(02269.HK$ and $Meituan-W(03690.HK$ .
For Southbound Trading of $SH->HK Connect(GangGuTong.HK$ , $CHINA MOBILE(00941.HK$ was the most active stock with highest net inflow of HKD265.8 million, while TENCENT was the most active stock with highest net outflow of HKD793.8 million.
For Southbound Trading of...
For Southbound Trading of $SH->HK Connect(GangGuTong.HK$ , $CHINA MOBILE(00941.HK$ was the most active stock with highest net inflow of HKD265.8 million, while TENCENT was the most active stock with highest net outflow of HKD793.8 million.
For Southbound Trading of...
Like
Comment
Share
Bocom outguns Wall Street forecasters on Chinese stocks with ‘playing offense’ call for 35 per cent upside next year
Chinese stocks are set to deliver the biggest payback for investors in six years, and “playing offense” is the way to go to capture the impending market rally, according to the $Bocom International Holdings(03329.HK$.
The MSCI China Index, which tracks 797 companies listed at home and abroad, will climb by 26.8 per cent to 34.9 per cent in 2023 as economic growth accelerates after a wider reopen...
The MSCI China Index, which tracks 797 companies listed at home and abroad, will climb by 26.8 per cent to 34.9 per cent in 2023 as economic growth accelerates after a wider reopen...
Like
Comment
Share
China’s retail sales shrink far more than expected
CHINA NOV RETAIL SALES Y/Y: -5.9% V -4.0%E [largest decline since May]; YTD Y/Y: -0.1% V +0.4%E CHINA NOV INDUSTRIAL PRODUCTION Y/Y: 2.2% V 3.5%E [slowest pace since May]; YTD Y/Y: 3.8% V 4.0%E China National Stats Bureau (NBS): Reiterates foundation for economic recovery still not solid, Economy operated within reasonable range during Nov CHINA NOV YTD FIXED URBAN ASSETS Y/Y: 5.3% V 5.6%E [slowest pace since Dec 2021] As China moves t...
Like
Comment
Share
In terms of allocation of Chinese stocks, it is suggested to focus on three main lines:
First, under the optimization of epidemic prevention, the repair market of damaged plates in the early stage, such as biomedical, aviation, wine travel and other plates; Second, under the demand of stable growth, the industry policy margin is loose, such as the real estate industry chain and the Internet and other industries; Third, under the theme of security for a long time, energy security, self contro...Like
Comment
Share
ColumnFundamentals Have Turned Positive and WuXi Biologics(02269.HK) is about to "Set Sail"?
$WUXI BIO(02269.HK$ is a global leader in biologics CRDMO (integrated business model from drug discovery to commercial production), with services covering the whole cycle of biologics development. With the accelerated aging of the population and the continued impact of epidemics, the biologics industry has a bright future. CITIC Securities analyzes the investment value of WuXi Biologics from two perspectives:...
Like
Comment
Share
Institution: outstanding performance price ratio of Hong Kong stock allocation
$TENCENT(00700.HK$$Meituan-W(03690.HK$$WUXI BIO(02269.HK$
After a long and deep downturn, the current valuation of Hong Kong shares has become more attractive. On the one hand, the dividend yield of telecom operators and state-owned big banks is close to or even more than 10%; On the other hand, the PE (TTM) of Hang Seng Technology Index has declined from 50 times of the high to 35 times of the current level...
After a long and deep downturn, the current valuation of Hong Kong shares has become more attractive. On the one hand, the dividend yield of telecom operators and state-owned big banks is close to or even more than 10%; On the other hand, the PE (TTM) of Hang Seng Technology Index has declined from 50 times of the high to 35 times of the current level...
Like
Comment
Share
Like
Comment
Share
Southbound Funds added positions to Tencent for 24 consecutive days
$Core Assets of North bound fund(BK1305.HK$ has bought $TENCENT(00700.HK$ net for 24 consecutive days from August 25 to yesterday, totaling about HKD 8.08707 billion.
According to the top ten traded shares of $SZ->HK Connect(BK1922.HK$ , $Hang Seng H-Share Index ETF(02828.HK$ , $WUXI BIO(02269.HK$, $Meituan-W(03690.HK$ , $TENCENT(00700.HK$ and $SUNNY OPTICAL(02382.HK$ were the most net buyers of Southbound Funds today, resp...
According to the top ten traded shares of $SZ->HK Connect(BK1922.HK$ , $Hang Seng H-Share Index ETF(02828.HK$ , $WUXI BIO(02269.HK$, $Meituan-W(03690.HK$ , $TENCENT(00700.HK$ and $SUNNY OPTICAL(02382.HK$ were the most net buyers of Southbound Funds today, resp...
Like
Comment
Share
$WUXI BIO(02269.HK$ now that it is doing share buybacks, looks like there is a price floor already. nowadays should only buy cash rich profitable companies, they can do share buybacks or buy over competitors at good valuation now without needing to incur more high interest rate debts.
Like
Comment
Share
No comment yet
Company Overview
More
Wuxi Biologics (Cayman), Inc. is an investment holding company, which engages in the discovery, development and manufacture of biologics services. Its services include testing; clinical drug substance cGMP manufacture; commercial drug substance cGMP manufacture; drug product cGMP fill and finish; antibody drug conjugates; regulatory affairs; and technologies and platforms. The company was founded on May 24, 2010 and is headquartered in Wuxi, China.
CEO： Dr. Chen Zhisheng
Market： Pink Market
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet